Drug
Placebo to NVA237
Placebo to NVA237 is a pharmaceutical drug with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
100%(2 trials)
Phase Distribution
Ph phase_4
1
25%
Ph phase_3
3
75%
Phase Distribution
0
Early Stage
0
Mid Stage
4
Late Stage
Phase Distribution4 total trials
Phase 3Large-scale testing
3(75.0%)
Phase 4Post-market surveillance
1(25.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
50.0%
2 of 4 finished
Non-Completion Rate
50.0%
2 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(2)
Terminated(2)
Detailed Status
Withdrawn2
Completed2
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 33 (75.0%)
Phase 41 (25.0%)
Trials by Status
withdrawn250%
completed250%
Recent Activity
0 active trials
Showing 4 of 4
withdrawnphase_3
Safety and Efficacy of NVA237 as an add-on to Fixed Dose Combination LABA/ICS
NCT01757015
withdrawnphase_3
Study of Efficacy and Safety of NVA237 in Patients With Poorly Controlled Asthma
NCT02127697
completedphase_4
Efficacy of NVA237 Compared to Tiotropium in Patients With Chronic Obstructive Pulmonary Disease (COPD)
NCT01922271
completedphase_3
Efficacy, Safety, and Tolerability of NVA237 Compared to Tiotropium in Patients With Chronic Obstructive Pulmonary Disease (COPD)
NCT01613326
Clinical Trials (4)
Showing 4 of 4 trials
NCT01757015Phase 3
Safety and Efficacy of NVA237 as an add-on to Fixed Dose Combination LABA/ICS
NCT02127697Phase 3
Study of Efficacy and Safety of NVA237 in Patients With Poorly Controlled Asthma
NCT01922271Phase 4
Efficacy of NVA237 Compared to Tiotropium in Patients With Chronic Obstructive Pulmonary Disease (COPD)
NCT01613326Phase 3
Efficacy, Safety, and Tolerability of NVA237 Compared to Tiotropium in Patients With Chronic Obstructive Pulmonary Disease (COPD)
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4